184 related articles for article (PubMed ID: 14531803)
1. Differential behavior of mesangial cells derived from 12/15-lipoxygenase knockout mice relative to control mice.
Kim YS; Reddy MA; Lanting L; Adler SG; Natarajan R
Kidney Int; 2003 Nov; 64(5):1702-14. PubMed ID: 14531803
[TBL] [Abstract][Full Text] [Related]
2. Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells.
Reddy MA; Adler SG; Kim YS; Lanting L; Rossi J; Kang SW; Nadler JL; Shahed A; Natarajan R
Am J Physiol Renal Physiol; 2002 Nov; 283(5):F985-94. PubMed ID: 12372774
[TBL] [Abstract][Full Text] [Related]
3. Reduced growth factor responses in vascular smooth muscle cells derived from 12/15-lipoxygenase-deficient mice.
Reddy MA; Kim YS; Lanting L; Natarajan R
Hypertension; 2003 Jun; 41(6):1294-300. PubMed ID: 12707289
[TBL] [Abstract][Full Text] [Related]
4. 12-lipoxygenase pathway increases aldosterone production, 3',5'-cyclic adenosine monophosphate response element-binding protein phosphorylation, and p38 mitogen-activated protein kinase activation in H295R human adrenocortical cells.
Gu J; Wen Y; Mison A; Nadler JL
Endocrinology; 2003 Feb; 144(2):534-43. PubMed ID: 12538614
[TBL] [Abstract][Full Text] [Related]
5. Relationship between 12/15-lipoxygenase and COX-2 in mesangial cells: potential role in diabetic nephropathy.
Xu ZG; Li SL; Lanting L; Kim YS; Shanmugam N; Reddy MA; Natarajan R
Kidney Int; 2006 Feb; 69(3):512-9. PubMed ID: 16514433
[TBL] [Abstract][Full Text] [Related]
6. Novel interactions between TGF-{beta}1 actions and the 12/15-lipoxygenase pathway in mesangial cells.
Kim YS; Xu ZG; Reddy MA; Li SL; Lanting L; Sharma K; Adler SG; Natarajan R
J Am Soc Nephrol; 2005 Feb; 16(2):352-62. PubMed ID: 15615821
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic Nephropathy.
Yuan H; Reddy MA; Deshpande S; Jia Y; Park JT; Lanting LL; Jin W; Kato M; Xu ZG; Das S; Natarajan R
Antioxid Redox Signal; 2016 Mar; 24(7):361-75. PubMed ID: 26492974
[TBL] [Abstract][Full Text] [Related]
8. 12-lipoxygenase is increased in glucose-stimulated mesangial cells and in experimental diabetic nephropathy.
Kang SW; Adler SG; Nast CC; LaPage J; Gu JL; Nadler JL; Natarajan R
Kidney Int; 2001 Apr; 59(4):1354-62. PubMed ID: 11260396
[TBL] [Abstract][Full Text] [Related]
9. The oxidized lipid and lipoxygenase product 12(S)-hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation. Mediation of angiotensin II effects.
Reddy MA; Thimmalapura PR; Lanting L; Nadler JL; Fatima S; Natarajan R
J Biol Chem; 2002 Mar; 277(12):9920-8. PubMed ID: 11786549
[TBL] [Abstract][Full Text] [Related]
10. p16ink4a Expression Is Increased through 12-Lipoxygenase in High Glucose-Stimulated Glomerular Mesangial Cells and Type 2 Diabetic Glomeruli.
Zhang YY; Guo QY; Wu MY; Zang CS; Ma FZ; Sun T; Wang WN; Miao LN; Xu ZG
Nephron; 2015; 130(2):141-50. PubMed ID: 26022507
[TBL] [Abstract][Full Text] [Related]
11. p38 MAPK and MAPK kinase 3/6 mRNA and activities are increased in early diabetic glomeruli.
Kang SW; Adler SG; Lapage J; Natarajan R
Kidney Int; 2001 Aug; 60(2):543-52. PubMed ID: 11473637
[TBL] [Abstract][Full Text] [Related]
12. High glucose-enhanced activation of mesangial cell p38 MAPK by ET-1, ANG II, and platelet-derived growth factor.
Tsiani E; Lekas P; Fantus IG; Dlugosz J; Whiteside C
Am J Physiol Endocrinol Metab; 2002 Jan; 282(1):E161-9. PubMed ID: 11739097
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of 12-lipoxygenase causes cardiac fibroblast cell growth.
Wen Y; Gu J; Liu Y; Wang PH; Sun Y; Nadler JL
Circ Res; 2001 Jan; 88(1):70-6. PubMed ID: 11139476
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of 12/15-lipoxygenase increases anxiety behavior in female mice.
Joshi YB; Di Meco A; Praticò D
Neurobiol Aging; 2014 May; 35(5):1032-6. PubMed ID: 24300237
[TBL] [Abstract][Full Text] [Related]
15. Products of 12/15-lipoxygenase upregulate the angiotensin II receptor.
Xu ZG; Yuan H; Lanting L; Li SL; Wang M; Shanmugam N; Kato M; Adler SG; Reddy MA; Natarajan R
J Am Soc Nephrol; 2008 Mar; 19(3):559-69. PubMed ID: 18235084
[TBL] [Abstract][Full Text] [Related]
16. 12-Lipoxygenase Inhibition on Microalbuminuria in Type-1 and Type-2 Diabetes Is Associated with Changes of Glomerular Angiotensin II Type 1 Receptor Related to Insulin Resistance.
Xu HZ; Cheng YL; Wang WN; Wu H; Zhang YY; Zang CS; Xu ZG
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27164093
[TBL] [Abstract][Full Text] [Related]
17. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
Francki A; McClure TD; Brekken RA; Motamed K; Murri C; Wang T; Sage EH
J Cell Biochem; 2004 Apr; 91(5):915-25. PubMed ID: 15034927
[TBL] [Abstract][Full Text] [Related]
18. Effects of silencing leukocyte-type 12/15-lipoxygenase using short interfering RNAs.
Li SL; Dwarakanath RS; Cai Q; Lanting L; Natarajan R
J Lipid Res; 2005 Feb; 46(2):220-9. PubMed ID: 15576842
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy.
Hou Y; Li S; Wu M; Wei J; Ren Y; Du C; Wu H; Han C; Duan H; Shi Y
Am J Physiol Renal Physiol; 2016 Mar; 310(6):F547-59. PubMed ID: 26719366
[TBL] [Abstract][Full Text] [Related]
20. Role of Src tyrosine kinase in the atherogenic effects of the 12/15-lipoxygenase pathway in vascular smooth muscle cells.
Reddy MA; Sahar S; Villeneuve LM; Lanting L; Natarajan R
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):387-93. PubMed ID: 19095999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
